Location History:
- Hawthorne, AU (1978)
- Victoria, AU (1993)
- Hawthorn, AU (1978 - 2015)
Company Filing History:
17 out of 21 
2 out of 89 Years Active: 1978-2015
Title: Geoffrey W. Tregear: Innovator in Relaxin Research
Introduction
Geoffrey W. Tregear, located in Hawthorn, Australia, is a distinguished inventor known for his significant contributions to medical science through his pioneering work on relaxin polypeptides. With a total of 19 patents to his name, his research has important implications for treatments related to anxiety and other health conditions.
Latest Patents
Tregear's recent patents focus on modified relaxin polypeptides, specifically featuring chimeric structures comprising both A and B chains derived from different relaxin family peptides. One of his latest innovations provides a detailed sequence for the B chain, anchored by the core amino acid sequence CGR-XXX-R-XX-I/V-XX-CG (SEQ ID NO:1), where X represents any amino acid. Additionally, Tregear has developed methods for the treatment of anxiety, describing human H3 preprorelaxin, prorelaxin, and various relaxin analogues. He also outlines nucleic acid sequences encoding these substances and their therapeutic methods.
Career Highlights
Throughout his career, Tregear has made significant strides in the realm of experimental physiology and medicine. He has held positions at prominent institutions, including the Howard Florey Institute of Experimental Physiology and Medicine and Armour Pharmaceutical Company. His work has not only advanced scientific knowledge but has also facilitated the development of potential treatments for various health conditions.
Collaborations
During his research journey, Tregear has collaborated with other notable scientists, including Hugh D. Niall and Peter J. Hudson. These collaborations have enabled him to enhance his research efforts, share ideas, and inspire innovations within the field of relaxin research.
Conclusion
Geoffrey W. Tregear's innovative work in relaxin polypeptides and related treatments underscores his role as an influential figure in the scientific community. With 19 patents to his credit, his inventions have the potential to reshape treatment approaches for anxiety and other medical conditions, highlighting the importance of continued research and innovation in this domain.